Latest Insider Transactions at Arcellx, Inc. (ACLX)
This section provides a real-time view of insider transactions for Arcellx, Inc. (ACLX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Arcellx, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Arcellx, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 26
2024
|
Christopher Heery CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,450
+27.47%
|
$32,700
$6.28 P/Share
|
|
Mar 22
2024
|
Christopher Heery CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
41,365
-31.24%
|
$2,895,550
$70.83 P/Share
|
|
Mar 22
2024
|
Christopher Heery CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+28.45%
|
$120,000
$6.28 P/Share
|
|
Mar 21
2024
|
Jill Carroll |
SELL
Open market or private sale
|
Indirect |
504,263
-25.42%
|
$35,298,410
$70.55 P/Share
|
|
Mar 18
2024
|
Michelle Gilson CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
6,825
-23.74%
|
$470,925
$69.38 P/Share
|
|
Mar 15
2024
|
Olivia C Ware |
SELL
Open market or private sale
|
Direct |
9,000
-58.04%
|
$630,000
$70.26 P/Share
|
|
Mar 15
2024
|
Olivia C Ware |
BUY
Exercise of conversion of derivative security
|
Direct |
9,000
+50.0%
|
$63,000
$7.61 P/Share
|
|
Feb 12
2024
|
Christopher Heery CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,967
-8.92%
|
$189,888
$64.46 P/Share
|
|
Feb 12
2024
|
Rami Elghandour |
SELL
Open market or private sale
|
Direct |
11,169
-10.79%
|
$714,816
$64.46 P/Share
|
|
Feb 09
2024
|
Christopher Heery CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,688
-9.98%
|
$232,344
$63.4 P/Share
|
|
Feb 09
2024
|
Rami Elghandour |
SELL
Open market or private sale
|
Direct |
13,886
-11.83%
|
$874,818
$63.4 P/Share
|
|
Feb 08
2024
|
Christopher Heery CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,456
-8.55%
|
$214,272
$62.29 P/Share
|
|
Feb 08
2024
|
Rami Elghandour |
SELL
Open market or private sale
|
Direct |
13,010
-9.98%
|
$806,620
$62.29 P/Share
|
|
Feb 07
2024
|
Rami Elghandour |
BUY
Exercise of conversion of derivative security
|
Direct |
70,211
+35.0%
|
-
|
|
Feb 07
2024
|
Christopher Heery CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
22,555
+35.82%
|
-
|
|
Jan 04
2024
|
Christopher Heery CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
7,598
-29.85%
|
$417,890
$55.27 P/Share
|
|
Jan 04
2024
|
Rami Elghandour |
SELL
Open market or private sale
|
Direct |
29,073
-32.57%
|
$1,599,015
$55.27 P/Share
|
|
Jan 04
2024
|
Michelle Gilson CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
8,514
-34.3%
|
$468,270
$55.27 P/Share
|
|
Jan 03
2024
|
Rami Elghandour |
BUY
Exercise of conversion of derivative security
|
Direct |
53,097
+37.3%
|
-
|
|
Jan 03
2024
|
Christopher Heery CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
16,519
+39.35%
|
-
|
|
Dec 18
2023
|
Christopher Heery CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
120,000
-50.69%
|
$6,000,000
$50.98 P/Share
|
|
Dec 18
2023
|
Christopher Heery CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
120,000
+48.43%
|
$720,000
$6.28 P/Share
|
|
Dec 14
2023
|
Jill Carroll |
SELL
Open market or private sale
|
Indirect |
504,263
-20.27%
|
$24,708,887
$49.13 P/Share
|
|
Aug 04
2023
|
Christopher Heery CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,000
-27.79%
|
$105,000
$35.38 P/Share
|
|
Aug 04
2023
|
Christopher Heery CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+21.75%
|
$45,000
$15.0 P/Share
|
|
Jul 03
2023
|
Christopher Heery CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,000
-27.79%
|
$93,000
$31.75 P/Share
|
|
Jul 03
2023
|
Christopher Heery CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+21.75%
|
$45,000
$15.0 P/Share
|
|
Jun 01
2023
|
Ali Behbahani |
BUY
Other acquisition or disposition
|
Indirect |
28
+24.78%
|
-
|
|
Jun 01
2023
|
Ali Behbahani |
BUY
Other acquisition or disposition
|
Direct |
113
+25.0%
|
-
|
|
Jun 01
2023
|
Jill Carroll |
SELL
Open market or private sale
|
Indirect |
25,556
-1.02%
|
$1,124,464
$44.35 P/Share
|
|
May 31
2023
|
Rami Elghandour |
SELL
Open market or private sale
|
Direct |
2,600
-6.71%
|
$114,400
$44.27 P/Share
|
|
May 31
2023
|
Jill Carroll |
SELL
Open market or private sale
|
Indirect |
315,164
-11.14%
|
$12,921,724
$41.5 P/Share
|
|
May 25
2023
|
Michelle Gilson CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
6,000
-38.75%
|
$252,000
$42.77 P/Share
|
|
May 24
2023
|
Michelle Gilson CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
8,704
-18.16%
|
$365,568
$42.06 P/Share
|
|
May 23
2023
|
Michelle Gilson CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
22,428
+48.11%
|
-
|
|
May 11
2023
|
Sr One Capital Management, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
1,012,833
-9.23%
|
$45,577,485
$45.58 P/Share
|
|
May 11
2023
|
Jill Carroll |
SELL
Open market or private sale
|
Indirect |
638,417
-9.23%
|
$28,728,765
$45.58 P/Share
|
|
May 10
2023
|
Christopher Heery CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,197
-21.99%
|
$98,865
$45.18 P/Share
|
|
May 09
2023
|
Christopher Heery CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
500
-4.77%
|
$22,500
$45.0 P/Share
|
|
May 05
2023
|
Christopher Heery CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,200
-10.26%
|
$54,000
$45.0 P/Share
|
|
May 03
2023
|
Christopher Heery CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,000
-10.46%
|
$129,000
$43.14 P/Share
|
|
May 03
2023
|
Christopher Heery CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+16.96%
|
$45,000
$15.0 P/Share
|
|
Apr 24
2023
|
Christopher Heery CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
20,000
-63.11%
|
$800,000
$40.0 P/Share
|
|
Apr 24
2023
|
Christopher Heery CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+27.77%
|
$200,000
$10.64 P/Share
|
|
Apr 19
2023
|
Christopher Heery CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
15,642
-57.23%
|
$547,470
$35.01 P/Share
|
|
Apr 19
2023
|
Christopher Heery CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
12,345
+19.58%
|
$123,450
$10.64 P/Share
|
|
Apr 18
2023
|
Christopher Heery CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
6,000
-28.59%
|
$210,000
$35.0 P/Share
|
|
Apr 18
2023
|
Christopher Heery CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,400
+12.08%
|
$54,000
$10.64 P/Share
|
|
Apr 03
2023
|
Christopher Heery CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,000
-8.24%
|
$90,000
$30.9 P/Share
|
|
Apr 03
2023
|
Christopher Heery CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+13.9%
|
$45,000
$15.0 P/Share
|